A mass in the stomach refers to an abnormal growth or lump, which could be benign (non-cancerous) or malignant (cancerous). It may present with symptoms such as pain, bloating, or unexplained weight loss. Diagnostic tests like imaging or a biopsy are essential for determining the nature of the mass and whether surgical removal or further treatment is required.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

The stomach sleeve diet follows the same principles as the gastric sleeve diet. After the surgery, patients must follow a structured eating plan, starting with liquids and progressing to solid foods over several weeks. The diet focuses on small, high-protein meals to support weight loss and ensure adequate nutrition.

A GI malignancy refers to any cancerous growth within the gastrointestinal tract. These cancers are often aggressive and can spread quickly if not detected early. Colon cancer, stomach cancer, and pancreatic cancer are common forms of GI malignancy. Gastroenterologists play a vital role in screening for these cancers through procedures like colonoscopies and endoscopies.

Roux-en-Y bypass is another term for the RNY procedure. This surgery helps patients lose weight by creating a small pouch from the stomach and connecting it directly to the small intestine, bypassing a portion of the digestive tract. The result is a reduced ability to absorb calories and nutrients. Patients who undergo RNY experience rapid weight loss, but it also requires them to make permanent changes to their diet and lifestyle to avoid complications like dumping syndrome, where food moves too quickly from the... +More